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Can reversal of RYGB also reverse
hypoglycemia?
Ipsa Arora 1, Mary-Elizabeth Patti 1,2,*
An increasing number of patients affected by excess weight have
turned to bariatric surgery for not only weight loss but also for
improved metabolic health. This perspective is supported by recent
data from controlled clinical trials highlighting the efﬁcacy of bariatric
surgery to resolve or improve obesity-related comorbidities including
type 2 diabetes, hypertension, and dyslipidemia. However, long-term
nutritional and metabolic complications require meticulous attention.
One of the most challenging complications is post-bariatric hypogly-
cemia (PBH), a syndrome typically detected >1 year after surgery. In
PBH, fasting glucose levels are normal, but shortly after eating, plasma
glucose levels rapidly “spike”, with subsequent rapid declines in
glucose, sometimes to hypoglycemic levels, within 1e3 h. The un-
derlying pathophysiology of this condition is complex, and includes
rapid gastric emptying, excessive postprandial secretion of incretin
hormones such as GLP-1, increased insulin secretion, and reductions
in counter regulatory hormone responses [1]. Remarkably, these and
other changes in systemic metabolism ultimately result from
surgically-induced alterations in gut anatomy and nutrient ﬂow
(Figure 1). Since current treatment approaches for PBH are not uni-
formly successful, Davis and colleagues now present results of a
prospective case series of 6 patients in whom surgery was performed
to reverse RYGB anatomy in order to treat severe PBH [2].
As a ﬁrst step to determine whether reversal of anatomy would
normalize meal-related hormonal and glycemic responses, a gastro-
stomy (G)-tube was placed in the excluded stomach, and a liquid
mixed meal was administered via the G-tube. With this approach,
nutrients would exit the remnant stomach via the pylorus and traverse
the biliopancreatic limb, mixing with biliary and pancreatic secretions,
yielding relative normalization of nutrient ﬂow. Indeed, a prior report
demonstrated that chronic G-tube feeding could be a successful
treatment for PBH [3]. In the current study, participants having im-
provements in glucose proﬁles and no hypoglycemia with the test meal
(delivered via the G-tube) were offered surgery, with 4 patients un-
dergoing conversion to sleeve gastrectomy and 2 patients undergoing
reversal to near-normal anatomy. Patients were followed for a mean of
20  15 months after revisional surgery. All reported improvement in
severity of symptomatic hypoglycemia, with reduction in episodes from
19 to 2 per week. Moreover, post-meal glucose, insulin, and GLP-1
excursions were signiﬁcantly diminished with both G-tube feeding
and after reversal surgery. Not surprisingly, modest weight regain was
observed, averaging 5 BMI units, but weight remained substantially
lower than pre-RYGB levels. Hormonal, metabolic, and weight proﬁles
did not differ when comparing those with reversal to sleeve gastrec-
tomy vs. reversal to normal anatomy.
Strengths of the current study are its paired design, with patients
acting as their own controls, and detailed hormonal analysis. However,
small sample size, variable surgical approaches, relatively short follow
up, and incomplete cohort data are signiﬁcant limiting factors. While
this study reports 100% success in improving hypoglycemia, previous
reports of even smaller series have noted variable responses. For
example, two patients with severe PBH had no improvement after
reversal [4]. Two additional case reports totaling six patients [5,6]
highlight the importance of a successful G-tube trial, while reversal
was successful even without a G-tube trial in 9 patients [7]. Never-
theless, selection bias could contribute to ﬁndings of beneﬁt in the
current study, as the patients who underwent revisional surgery all had
successful G-tube meal trials. Information on the screening of potential
candidates, with focus on the percentage of patients who did or did not
have improved patterns with G-tube feeding, would be helpful to
understand the overall success of revisional surgery.
Variation in surgical techniques for RYGB and its revision to sleeve
gastrectomy or near-normal anatomy may also contribute to variable
responses. For example, does reversal include resection of the roux
limb, implicated as a potential contributor to incretin secretion and
postprandial intestinal glucose uptake [8]? The technique utilized in the
current report was similar to another report [6] but differed from others
[4,5,7]. Despite these variables, 10 of the 12 patients in published
reports showed improvement in hypoglycemia.
Differential effects on gastric emptying could also impact response to
revisional surgery. In our experience, patients often experience
symptoms of delayed gastric emptying, such as persistent nausea and
vomiting, after revisional surgery. Slowed emptying may contribute to
improvements in glycemia but may sometimes require additional
surgical procedures for symptom relief. Other factors which may
contribute to variable responses include gut microbiota, bile acids,
dietary composition, intestinal adaptive responses, and changes in
blood ﬂow and innervation (which may not be fully reversible). Finally,
inter-individual differences in glucose metabolism and insulin secre-
tion, present prior to original RYGB, may contribute to PBH, and these
may remain despite revision in a subset of patients.
Should we recommend reversal of RYGB for patients with severe PBH?
The current study supports the hypothesis that altered nutrient ﬂow
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contributes to disordered glycemia after RYGB and provides some
optimism that normalization of nutrient ﬂow by either chronic G-tube
feeding [3] or conversion to sleeve gastrectomy or nearly-normal
anatomy, when possible, could be effective for some patients. How-
ever, given the reported variability in response and small cohorts to
date, additional studies addressing the long-term efﬁcacy, and factors
associated with beneﬁcial responses, will be required before revisional
surgery can be universally recommended. Moreover, it will be
important to deﬁne whether G-tube meal responses can be used to
predict success, and to identify the duration of G-tube feeding required
to achieve optimal predictive value, as restoration of nutrient ﬂow may
continue to modulate intestinal remodeling and hormonal responses
with time [5]. In the interim, we recommend medical nutrition therapy
to limit intake of simple carbohydrates, use of disaccharidase inhibitors
such as acarbose, and medications to limit incretin and insulin
secretion when needed [9]. Although initial reports indicated beneﬁt of
partial pancreatectomy, subsequent studies showed incomplete efﬁ-
cacy over time [10]. Adjunctive measures, such as real-time contin-
uous glucose monitoring with predictive alarms which permit self-
treatment before neuroglycopenia develops, may improve safety.
More importantly, a full understanding of the underlying pathophysi-
ology of PBH is required to allow clinicians to identify patients at
highest risk for developing PBH during preoperative assessment, and
thus prevent this serious complication.
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Figure 1: Schematic of differences in glucose and hormonal patterns in patients with (A) hypoglycemia after RYGB surgery and (B) after RYGB reversal surgery.
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